 LEXINGTON, Mass., April 28, 2021 GLOBE NEWSWIRE -- Agenus NASDAQ: AGEN, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that it will give two presentations at the 2021 American Society for Clinical Oncology ASCO Annual Meeting poster sessions. The ASCO meeting will be held from June 4 8, 2021. 